173 related articles for article (PubMed ID: 32646486)
1. Genes adapt to outsmart gene-targeting strategies in mutant mouse strains by skipping exons to reinitiate transcription and translation.
Hosur V; Low BE; Li D; Stafford GA; Kohar V; Shultz LD; Wiles MV
Genome Biol; 2020 Jul; 21(1):168. PubMed ID: 32646486
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-Mediated Insertion of loxP Sites in the Mouse Dock7 Gene Provides an Effective Alternative to Use of Targeted Embryonic Stem Cells.
Bishop KA; Harrington A; Kouranova E; Weinstein EJ; Rosen CJ; Cui X; Liaw L
G3 (Bethesda); 2016 Jul; 6(7):2051-61. PubMed ID: 27175020
[TBL] [Abstract][Full Text] [Related]
3. TEAD4 regulates trophectoderm differentiation upstream of CDX2 in a GATA3-independent manner in the human preimplantation embryo.
Stamatiadis P; Cosemans G; Boel A; Menten B; De Sutter P; Stoop D; Chuva de Sousa Lopes SM; Lluis F; Coucke P; Heindryckx B
Hum Reprod; 2022 Jul; 37(8):1760-1773. PubMed ID: 35700449
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
5. Efficient gene targeting in mouse zygotes mediated by CRISPR/Cas9-protein.
Jung CJ; Zhang J; Trenchard E; Lloyd KC; West DB; Rosen B; de Jong PJ
Transgenic Res; 2017 Apr; 26(2):263-277. PubMed ID: 27905063
[TBL] [Abstract][Full Text] [Related]
6. Unexpected consequences: exon skipping caused by CRISPR-generated mutations.
Sharpe JJ; Cooper TA
Genome Biol; 2017 Jun; 18(1):109. PubMed ID: 28615035
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of single-stranded DNA donors to generate conditional null mouse alleles.
Lanza DG; Gaspero A; Lorenzo I; Liao L; Zheng P; Wang Y; Deng Y; Cheng C; Zhang C; Seavitt JR; DeMayo FJ; Xu J; Dickinson ME; Beaudet AL; Heaney JD
BMC Biol; 2018 Jun; 16(1):69. PubMed ID: 29925370
[TBL] [Abstract][Full Text] [Related]
8. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
[TBL] [Abstract][Full Text] [Related]
9. Machine learning based CRISPR gRNA design for therapeutic exon skipping.
Louie W; Shen MW; Tahiry Z; Zhang S; Worstell D; Cassa CA; Sherwood RI; Gifford DK
PLoS Comput Biol; 2021 Jan; 17(1):e1008605. PubMed ID: 33417623
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human
Egorova TV; Zotova ED; Reshetov DA; Polikarpova AV; Vassilieva SG; Vlodavets DV; Gavrilov AA; Ulianov SV; Buchman VL; Deykin AV
Dis Model Mech; 2019 Apr; 12(4):. PubMed ID: 31028078
[TBL] [Abstract][Full Text] [Related]
11. Gene Editing in Mouse Zygotes Using the CRISPR/Cas9 System.
Wefers B; Wurst W; Kühn R
Methods Mol Biol; 2023; 2631():207-230. PubMed ID: 36995669
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-mediated genome editing induces exon skipping by complete or stochastic altering splicing in the migratory locust.
Chen D; Tang JX; Li B; Hou L; Wang X; Kang L
BMC Biotechnol; 2018 Sep; 18(1):60. PubMed ID: 30253761
[TBL] [Abstract][Full Text] [Related]
13. Variation in zygotic CRISPR/Cas9 gene editing outcomes generates novel reporter and deletion alleles at the Gdf11 locus.
Goldstein JM; Valido A; Lewandowski JP; Walker RG; Mills MJ; Messemer KA; Besseling P; Lee KH; Wattrus SJ; Cho M; Lee RT; Wagers AJ
Sci Rep; 2019 Dec; 9(1):18613. PubMed ID: 31819086
[TBL] [Abstract][Full Text] [Related]
14. Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.
Kim YS; Kim GR; Park M; Yang SC; Park SH; Won JE; Lee JH; Shin HE; Song H; Kim HR
Tissue Eng Regen Med; 2020 Feb; 17(1):45-53. PubMed ID: 32002841
[TBL] [Abstract][Full Text] [Related]
15. Direct Generation of Conditional Alleles Using CRISPR/Cas9 in Mouse Zygotes.
Pritchard CEJ; Kroese LJ; Huijbers IJ
Methods Mol Biol; 2017; 1642():21-35. PubMed ID: 28815491
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases.
Pendse ND; Lamas V; Pawlyk BS; Maeder ML; Chen ZY; Pierce EA; Liu Q
Adv Exp Med Biol; 2019; 1185():91-96. PubMed ID: 31884594
[TBL] [Abstract][Full Text] [Related]
17. Restoration of Dystrophin Protein Expression by Exon Skipping Utilizing CRISPR-Cas9 in Myoblasts Derived from DMD Patient iPS Cells.
Ifuku M; Iwabuchi KA; Tanaka M; Lung MSY; Hotta A
Methods Mol Biol; 2018; 1828():191-217. PubMed ID: 30171543
[TBL] [Abstract][Full Text] [Related]
18. Generation of site-specific mutant mice using the CRISPR/Cas9 system.
Bai M; Li Q; Shao YJ; Huang YH; Li DL; Ma YL
Yi Chuan; 2015 Oct; 37(10):1029-35. PubMed ID: 26496755
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion.
Mou H; Smith JL; Peng L; Yin H; Moore J; Zhang XO; Song CQ; Sheel A; Wu Q; Ozata DM; Li Y; Anderson DG; Emerson CP; Sontheimer EJ; Moore MJ; Weng Z; Xue W
Genome Biol; 2017 Jun; 18(1):108. PubMed ID: 28615073
[TBL] [Abstract][Full Text] [Related]
20. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.
Hanson B; Wood MJA; Roberts TC
RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
